학술논문

Mitophagy is a novel protective mechanism for drug-tolerant persister (DTP) cancer cells.
Document Type
article
Source
Autophagy. 19(9)
Subject
Drug-tolerant persister
MAPK inhibitor
PINK1
mitophagy
quiescent cancer cells
Mitophagy
Autophagy
Cell Line
Tumor
Mitochondria
Protein Kinases
Ubiquitin-Protein Ligases
Neoplasms
Language
Abstract
Drug-tolerant persister (DTP) cancer cells drive residual tumor and relapse. However, the mechanisms underlying DTP state development are largely unexplored. In a recent study, we determined that PINK1-mediated mitophagy favors DTP generation in the context of MAPK inhibition therapy. DTP cells that persist in the presence of a MAPK inhibitor exhibit mitochondriadependent metabolism. During DTP state development, MYC depletion alleviates the transcriptional repression of PINK1, resulting in PINK1 upregulation and mitophagy activation. PINK1-mediated mitophagy is essential for mitochondrial homeostasis in DTP cells. Either knockdown of PINK1 or inhibition of mitophagy eradicates DTP cells and achieves complete responses to MAPK inhibition therapy. This study reveals a novel role of mitophagy as a protective mechanism for DTP development.